Annual Operating Expenses
$50.09 M
+$3.87 M+8.38%
December 31, 2023
Summary
- As of February 7, 2025, ABEO annual total operating expenses is $50.09 million, with the most recent change of +$3.87 million (+8.38%) on December 31, 2023.
- During the last 3 years, ABEO annual operating expenses has fallen by -$8.41 million (-14.37%).
- ABEO annual operating expenses is now -35.02% below its all-time high of $77.09 million, reached on December 31, 2019.
Performance
ABEO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$15.35 M
-$2.52 M-14.10%
September 30, 2024
Summary
- As of February 7, 2025, ABEO quarterly total operating expenses is $15.35 million, with the most recent change of -$2.52 million (-14.10%) on September 30, 2024.
- Over the past year, ABEO quarterly operating expenses has increased by +$2.14 million (+16.17%).
- ABEO quarterly operating expenses is now -36.00% below its all-time high of $23.98 million, reached on June 30, 2019.
Performance
ABEO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ABEO Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +8.4% | +16.2% |
3 y3 years | -14.4% | +3.2% |
5 y5 years | -18.1% | -13.1% |
ABEO Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -17.0% | +8.4% | -14.1% | +63.6% |
5 y | 5-year | -35.0% | +8.4% | -14.1% | +63.6% |
alltime | all time | -35.0% | +1823.8% | -36.0% | +1328.6% |
Abeona Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $15.35 M(-14.1%) |
Jun 2024 | - | $17.86 M(+24.7%) |
Mar 2024 | - | $14.33 M(+8.5%) |
Dec 2023 | $50.09 M(+8.4%) | $13.21 M(+16.9%) |
Sep 2023 | - | $11.30 M(-16.5%) |
Jun 2023 | - | $13.54 M(+12.5%) |
Mar 2023 | - | $12.04 M(+0.7%) |
Dec 2022 | $46.22 M(-23.4%) | $11.95 M(+27.4%) |
Sep 2022 | - | $9.38 M(-7.3%) |
Jun 2022 | - | $10.12 M(-31.5%) |
Mar 2022 | - | $14.77 M(-14.1%) |
Dec 2021 | $60.37 M(+3.2%) | $17.19 M(+15.6%) |
Sep 2021 | - | $14.87 M(+8.4%) |
Jun 2021 | - | $13.71 M(-6.0%) |
Mar 2021 | - | $14.60 M(-16.5%) |
Dec 2020 | $58.50 M(-24.1%) | $17.48 M(+31.9%) |
Sep 2020 | - | $13.25 M(+6.1%) |
Jun 2020 | - | $12.48 M(-18.4%) |
Mar 2020 | - | $15.29 M(-6.8%) |
Dec 2019 | $77.09 M(+26.0%) | $16.41 M(-7.0%) |
Sep 2019 | - | $17.65 M(-26.4%) |
Jun 2019 | - | $23.98 M(+25.8%) |
Mar 2019 | - | $19.05 M(+3.0%) |
Dec 2018 | $61.16 M(+113.3%) | $18.49 M(-0.7%) |
Sep 2018 | - | $18.63 M(+45.1%) |
Jun 2018 | - | $12.83 M(+14.4%) |
Mar 2018 | - | $11.21 M(+25.1%) |
Dec 2017 | $28.67 M(+15.8%) | $8.96 M(+60.6%) |
Sep 2017 | - | $5.58 M(-35.5%) |
Jun 2017 | - | $8.66 M(+58.3%) |
Mar 2017 | - | $5.47 M(-10.2%) |
Dec 2016 | $24.77 M(+26.5%) | $6.09 M(+13.6%) |
Sep 2016 | - | $5.36 M(-22.7%) |
Jun 2016 | - | $6.93 M(+8.4%) |
Mar 2016 | - | $6.39 M(-1.1%) |
Dec 2015 | $19.59 M(+382.9%) | $6.47 M(+0.3%) |
Sep 2015 | - | $6.45 M(+46.3%) |
Jun 2015 | - | $4.41 M(+95.1%) |
Mar 2015 | - | $2.26 M(+222.4%) |
Dec 2014 | $4.06 M(-29.1%) | $701.00 K(-19.3%) |
Sep 2014 | - | $869.00 K(-8.5%) |
Jun 2014 | - | $950.00 K(-38.2%) |
Mar 2014 | - | $1.54 M(+81.6%) |
Dec 2013 | $5.72 M(-32.3%) | $846.00 K(-3.6%) |
Sep 2013 | - | $878.00 K(-62.4%) |
Jun 2013 | - | $2.33 M(+40.5%) |
Mar 2013 | - | $1.66 M(-23.0%) |
Dec 2012 | $8.45 M(-11.6%) | $2.16 M(+23.5%) |
Sep 2012 | - | $1.75 M(-15.9%) |
Jun 2012 | - | $2.08 M(-15.7%) |
Mar 2012 | - | $2.47 M(+14.9%) |
Dec 2011 | $9.57 M | $2.15 M(-22.3%) |
Sep 2011 | - | $2.76 M(+16.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | - | $2.37 M(+7.2%) |
Mar 2011 | - | $2.21 M(+17.1%) |
Dec 2010 | $8.10 M(-19.2%) | $1.89 M(-22.2%) |
Sep 2010 | - | $2.42 M(+18.5%) |
Jun 2010 | - | $2.04 M(+17.2%) |
Mar 2010 | - | $1.75 M(-2.5%) |
Dec 2009 | $10.03 M(-67.7%) | $1.79 M(-56.2%) |
Sep 2009 | - | $4.08 M(+89.5%) |
Jun 2009 | - | $2.15 M(+7.8%) |
Mar 2009 | - | $2.00 M(+10.6%) |
Dec 2008 | $31.02 M(+345.9%) | $1.81 M(-53.8%) |
Sep 2008 | - | $3.92 M(+71.3%) |
Jun 2008 | - | $2.29 M(-78.4%) |
Mar 2008 | - | $10.60 M(+440.0%) |
Dec 2007 | $6.96 M(+34.4%) | $1.96 M(+18.5%) |
Sep 2007 | - | $1.66 M(-3.1%) |
Jun 2007 | - | $1.71 M(+5.1%) |
Mar 2007 | - | $1.63 M(+55.5%) |
Dec 2006 | $5.17 M(-46.2%) | $1.05 M(-16.7%) |
Sep 2006 | - | $1.26 M(-8.6%) |
Jun 2006 | - | $1.37 M(-8.3%) |
Mar 2006 | - | $1.50 M(-67.2%) |
Dec 2005 | $9.62 M(+60.3%) | $4.57 M(+285.7%) |
Sep 2005 | - | $1.19 M(-53.6%) |
Jun 2005 | - | $2.55 M(+94.4%) |
Mar 2005 | - | $1.31 M(-304.5%) |
Dec 2004 | $6.00 M(+10.6%) | -$642.00 K(-127.0%) |
Sep 2004 | - | $2.37 M(+7.3%) |
Jun 2004 | - | $2.21 M(+7.5%) |
Mar 2004 | - | $2.06 M(-264.8%) |
Dec 2003 | $5.43 M(-44.3%) | -$1.25 M(-164.9%) |
Sep 2003 | - | $1.92 M(-15.4%) |
Jun 2003 | - | $2.27 M(-8.3%) |
Mar 2003 | - | $2.48 M(-8.7%) |
Dec 2002 | $9.74 M(+48.7%) | $2.71 M(-1.9%) |
Sep 2002 | - | $2.77 M(+16.2%) |
Jun 2002 | - | $2.38 M(+26.7%) |
Mar 2002 | - | $1.88 M(+20.4%) |
Dec 2001 | $6.55 M(+6.3%) | $1.56 M(-15.8%) |
Sep 2001 | - | $1.85 M(+16.4%) |
Jun 2001 | - | $1.59 M(+3.4%) |
Mar 2001 | - | $1.54 M(-19.1%) |
Dec 2000 | $6.17 M(+83.3%) | $1.90 M(+27.5%) |
Sep 2000 | - | $1.49 M(-10.5%) |
Jun 2000 | - | $1.67 M(+51.6%) |
Mar 2000 | - | $1.10 M(+14.1%) |
Dec 1999 | $3.36 M(-3.9%) | $964.00 K(+37.7%) |
Sep 1999 | - | $700.00 K(-12.5%) |
Jun 1999 | - | $800.00 K(0.0%) |
Mar 1999 | - | $800.00 K |
Dec 1998 | $3.50 M(-20.1%) | - |
Dec 1997 | $4.38 M(+26.3%) | - |
Dec 1996 | $3.47 M(+33.1%) | - |
Dec 1995 | $2.60 M | - |
FAQ
- What is Abeona Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Abeona Therapeutics?
- What is Abeona Therapeutics annual operating expenses year-on-year change?
- What is Abeona Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly operating expenses year-on-year change?
What is Abeona Therapeutics annual total operating expenses?
The current annual operating expenses of ABEO is $50.09 M
What is the all time high annual operating expenses for Abeona Therapeutics?
Abeona Therapeutics all-time high annual total operating expenses is $77.09 M
What is Abeona Therapeutics annual operating expenses year-on-year change?
Over the past year, ABEO annual total operating expenses has changed by +$3.87 M (+8.38%)
What is Abeona Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ABEO is $15.35 M
What is the all time high quarterly operating expenses for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly total operating expenses is $23.98 M
What is Abeona Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ABEO quarterly total operating expenses has changed by +$2.14 M (+16.17%)